Did NIOSH develop this list?
Neither NIOSH nor the Advisory Board on Radiation and Worker Health developed the list of 22 "specified cancers," and neither can modify the list. The list is part of the EEOICPA statute, and only Congress can modify the list of "specified cancers." The origin for the list of "specified cancers" began in the Radiation-Exposed Veterans Compensation Act (REVCA) of 1988. The Radiation-Exposed Veterans Compensation Act's original list included 13 cancers that were based on published reports from National Research Council Committees that identified elevated risks of contracting these cancers after exposure to radiation. This list of 13 cancers was then incorporated into the original enactment of the Radiation Exposure Compensation Act in 1990. In 2000, the Radiation Exposure Compensation Act was amended to incorporate a variety of changes, including the addition of 6 more specified cancers. The list of "specified cancers" for inclusion in the SEC is comprised of 22 cancers: 19 cancers specified in RECA; renal and bone cancers as specified in EEOICPA; and male and female breast cancers, which are considered separately under EEOICPA.
The following table shows a comparison of the "specified cancers" under the Radiation Exposure Compensation Act, the Radiation-Exposed Veterans Compensation Act, and EEOICPA.
Cancer site
|
REVCA
and RECA (1990) |
RECA (2000)2
|
EEOICPA
|
|---|---|---|---|
| Bile duct |
X
|
X
|
X
|
| Bone |
X
| ||
| Brain |
X
|
X
| |
| Breast (female and male) |
X
|
X
|
X
|
| Colon |
X
|
X
| |
| Esophagus |
X
|
X
|
X
|
| Gall bladder |
X
|
X
|
X
|
| Kidney |
X
| ||
| Leukemia (exc. CLL) |
X
|
X
|
X
|
| Liver |
X
|
X
|
X
|
| Lung |
X
|
X
| |
| Lymphoma (NHL) |
X
|
X
|
X
|
| Multiple myeloma |
X
|
X
|
X
|
| Ovary |
X
|
X
| |
| Pancreas |
X
|
X
|
X
|
| Pharynx |
X
|
X
|
X
|
| Salivary gland |
X
|
X
| |
| Small intestine |
X
|
X
|
X
|
| Stomach |
X
|
X
|
X
|
| Thyroid |
X
|
X
|
X
|
| Urinary bladder |
X
|
X
|
1This table is provided for comparison purposes only and does not include other requirements that might apply, such as latency period and primary and tumor status (i.e., primary or secondary).
2This list is specifically for those cancers covered by RECA under open- air nuclear testing.
No comments:
Post a Comment